Literature DB >> 25189643

Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis.

Akihiro Yanagisawa1, Mitsuharu Ueda2, Takanao Sueyoshi3, Tatsuya Okada3, Toru Fujimoto3, Yasuhiro Ogi2, Keisuke Kitagawa2, Masayoshi Tasaki2, Yohei Misumi2, Toshinori Oshima2, Hirofumi Jono4, Konen Obayashi5, Kei Hirakawa6, Hitoshi Uchida6, Per Westermark7, Yukio Ando2, Hiroshi Mizuta3.   

Abstract

Amyloidosis is a protein conformational disorder with the distinctive feature of extracellular accumulation of amyloid fibrils that come from different proteins. In the ligamentum flavum of the lumbar spine, amyloid deposits were frequently found in elderly patients with lumbar spinal canal stenosis and were at least partially formed by wild-type transthyretin. However, how amyloid deposits in the ligamentum flavum affect lumbar spinal canal stenosis has remained unclear. In this study, we analyzed clinical, pathologic, and radiologic findings of patients with lumbar spinal canal stenosis who had amyloid deposits in the ligamentum flavum. We studied 95 ligamentum flavum specimens obtained from 56 patients with lumbar spinal canal stenosis and 21 ligamentum flavum specimens obtained from 19 patients with lumbar disk herniation. We evaluated histopathologic findings and clinicoradiologic manifestations, such as thickness of the ligamentum flavum and lumbar spinal segmental instability. We found that all 95 ligamentum flavum specimens resected from patients with lumbar spinal canal stenosis had amyloid deposits, which we classified into two types, transthyretin-positive and transthyretin-negative, and that transthyretin amyloid formation in the ligamentum flavum of patients with lumbar spinal canal stenosis was an age-associated phenomenon. The amount of amyloid in the ligamentum flavum was related to clinical manifestations of lumbar spinal canal stenosis, such as thickness of the ligamentum flavum and lumbar spinal segmental instability, in the patients with lumbar spinal canal stenosis with transthyretin-positive amyloid deposits. To our knowledge, this report is the first to show clinicopathologic correlations in transthyretin amyloid deposits of the ligamentum flavum. In conclusion, transthyretin amyloid deposits in the ligamentum flavum may be related to the pathogenesis of lumbar spinal canal stenosis in elderly patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25189643     DOI: 10.1038/modpathol.2014.102

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  23 in total

1.  Lumbar spinal stenosis and spondylosis associated with amyloid deposition in the ligamentum flavum.

Authors:  A N D'Agostino; M S Mason; S F Quinn
Journal:  Clin Neuropathol       Date:  1992 May-Jun       Impact factor: 1.368

2.  Application of formalin fixation to the purification of amyloid proteins.

Authors:  R Layfield; K Bailey; R Dineen; P Mehrotra; J Lowe; R Allibone; R J Mayer; M Landon
Journal:  Anal Biochem       Date:  1997-11-01       Impact factor: 3.365

Review 3.  Diagnosis and therapeutic approaches to transthyretin amyloidosis.

Authors:  Y Ando; M Ueda
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 4.  Transthyretin-related familial amyloidotic polyneuropathy.

Authors:  Yukio Ando; Masaaki Nakamura; Shukuro Araki
Journal:  Arch Neurol       Date:  2005-07

5.  Spinal multifocal amyloidosis derived from wild-type transthyretin.

Authors:  Takanao Sueyoshi; Mitsuharu Ueda; Akira Sei; Yohei Misumi; Toshinori Oshima; Taro Yamashita; Konen Obayashi; Satoru Shinriki; Hirofumi Jono; Makoto Shono; Yukio Ando; Hiroshi Mizuta
Journal:  Amyloid       Date:  2011-06-01       Impact factor: 7.141

6.  Spinal cord claudication from amyloid deposition.

Authors:  S Honig; R Murali
Journal:  J Rheumatol       Date:  1992-12       Impact factor: 4.666

Review 7.  Recent progress in understanding dialysis-related amyloidosis.

Authors:  Suguru Yamamoto; Junichiro James Kazama; Ichiei Narita; Hironobu Naiki; Fumitake Gejyo
Journal:  Bone       Date:  2009-03-19       Impact factor: 4.398

Review 8.  The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.

Authors:  G Merlini; P Westermark
Journal:  J Intern Med       Date:  2004-02       Impact factor: 8.989

9.  Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis.

Authors:  Elisabet Ihse; Ole B Suhr; Ulf Hellman; Per Westermark
Journal:  J Mol Med (Berl)       Date:  2010-11-25       Impact factor: 4.599

10.  Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis.

Authors:  Per Westermark; Gunilla T Westermark; Ole B Suhr; Svante Berg
Journal:  Ups J Med Sci       Date:  2014-03-12       Impact factor: 2.384

View more
  31 in total

Review 1.  Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.

Authors:  Frederick L Ruberg; Martha Grogan; Mazen Hanna; Jeffery W Kelly; Mathew S Maurer
Journal:  J Am Coll Cardiol       Date:  2019-06-11       Impact factor: 24.094

Review 2.  Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Sabahat Bokhari; Thibaud Damy; Sharmila Dorbala; Brian M Drachman; Marianna Fontana; Martha Grogan; Arnt V Kristen; Isabelle Lousada; Jose Nativi-Nicolau; Candida Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Ronald Witteles; Giampaolo Merlini
Journal:  Circ Heart Fail       Date:  2019-09-04       Impact factor: 8.790

3.  A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.

Authors:  Mitsuharu Ueda; Masamitsu Okada; Mineyuki Mizuguchi; Barbara Kluve-Beckerman; Kyosuke Kanenawa; Aito Isoguchi; Yohei Misumi; Masayoshi Tasaki; Akihiko Ueda; Akinori Kanai; Ryoko Sasaki; Teruaki Masuda; Yasuteru Inoue; Toshiya Nomura; Satoru Shinriki; Tsuyoshi Shuto; Hirofumi Kai; Taro Yamashita; Hirotaka Matsui; Merrill D Benson; Yukio Ando
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

4.  True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis.

Authors:  Avinainder Singh; Hallie I Geller; Kevin M Alexander; Robert F Padera; Richard N Mitchell; Sharmila Dorbala; Jorge J Castillo; Rodney H Falk
Journal:  Haematologica       Date:  2018-04-19       Impact factor: 9.941

5.  Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?

Authors:  Fabian Aus dem Siepen; Selina Hein; Sofie Prestel; Christian Baumgärtner; Stefan Schönland; Ute Hegenbart; Christoph Röcken; Hugo A Katus; Arnt V Kristen
Journal:  Clin Res Cardiol       Date:  2019-04-05       Impact factor: 5.460

Review 6.  Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.

Authors:  Vasiliki Bistola; John Parissis; Emmanouil Foukarakis; Pipitsa N Valsamaki; Aris Anastasakis; Georgios Koutsis; Georgios Efthimiadis; Efstathios Kastritis
Journal:  Heart Fail Rev       Date:  2021-01-15       Impact factor: 4.214

Review 7.  Multidisciplinary Approaches for Transthyretin Amyloidosis.

Authors:  Haruki Koike; Takahiro Okumura; Toyoaki Murohara; Masahisa Katsuno
Journal:  Cardiol Ther       Date:  2021-06-04

8.  A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.

Authors:  Ahsan Huda; Adam Castaño; Anindita Niyogi; Jennifer Schumacher; Michelle Stewart; Marianna Bruno; Mo Hu; Faraz S Ahmad; Rahul C Deo; Sanjiv J Shah
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 17.694

9.  Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis.

Authors:  P Eldhagen; S Berg; L H Lund; P Sörensson; O B Suhr; P Westermark
Journal:  J Intern Med       Date:  2021-01-07       Impact factor: 8.989

10.  WISP-1 induced by mechanical stress contributes to fibrosis and hypertrophy of the ligamentum flavum through Hedgehog-Gli1 signaling.

Authors:  Chao Sun; Qinghong Ma; Jian Yin; Han Zhang; Xinhui Liu
Journal:  Exp Mol Med       Date:  2021-06-22       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.